首页> 外文期刊>Biotechnology Progress >Human chymotrypsinogen B production from Pichia pastoris by integrateddevelopment of fermentation and downstream processing. Part 2. Proteinrecovery
【24h】

Human chymotrypsinogen B production from Pichia pastoris by integrateddevelopment of fermentation and downstream processing. Part 2. Proteinrecovery

机译:通过发酵和下游加工的综合发展从巴斯德毕赤酵母生产人胰凝乳蛋白酶原B。第2部分。蛋白质回收

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

The purification of human chymotrypsinogen B (hCTRB) after expression and secretion by the yeast Pichia pastoris is described based on two different approaches using integrated initial recovery. Extraction employing aqueous two-phase systems (ATPS) from poly(ethylene glycol) and sodium sulfate allows direct processing of cell containing yeast suspensions of 50% wet weight. The target protein is obtained partially purified in the top phase while cells and cell debris are partitioned to the bottom phase of the system. hCTRB is further purified by adsorption from the top phase to the cation exchanger SP Sepharose Big Beads and elution in a salt step. The single step isolation of hCTRB is possible by expanded bed adsorption (EBA) using a fluidized cation exchanger (Streamline SP XL). A design strategy is shown taking both target protein binding and stable fluidization of the stationary phase in cell containing suspensions into consideration. For the example of hCTRB isolation from cell containing P. pastoris suspensions, a successful use of this strategy is demonstrated. Both initial recovery strategies deliver a product that can be further purified and formulated by ultrafiltration/diafiltration followed by lyophilization, resulting in a homogeneous product. Scale-up to 30-90 L of culture suspension was shown for both methods, resulting in a product of similar quality. Comparing both strategies reveals that the two-step ATPS route is better suited for high cell density cultures, while the single step EBA method is preferred for cultures of moderate cell density. This is due to the fact that application of EBA is restricted to suspensions of 10-12.5% wet weight cell concentration, thus necessitating dilution of the original broth prior to sample application. The data presented show that integrated recovery operations are a valuable alternative to traditional processing for systems that are problematic during initial solid-liquid separation.
机译:酵母巴斯德毕赤酵母表达和分泌后,对人胰凝乳蛋白酶原B(hCTRB)的纯化是基于两种使用整合初始回收的不同方法进行的。使用含水的两相系统(ATPS)从聚乙二醇和硫酸钠中萃取可直接处理含细胞的湿重为50%的酵母悬浮液。靶蛋白是在顶相中部分纯化的,而细胞和细胞碎片则分配到系统的底相。通过从顶层吸附至阳离子交换剂SP Sepharose Big Beads并在盐分步骤中洗脱,进一步纯化hCTRB。 hCTRB的一步分离可通过使用流化阳离子交换剂(Streamline SP XL)的扩展床吸附(EBA)实现。显示了一种设计策略,该策略同时考虑了目标蛋白结合和包含细胞的悬浮液中固定相的稳定流态化。对于从含有巴斯德毕赤酵母悬液的细胞中分离hCTRB的示例,已证明该策略的成功使用。两种初始回收策略均提供了可以通过超滤/渗滤,然后冻干进一步纯化和配制的产品,从而得到均质的产品。两种方法均显示放大至30-90 L的培养悬浮液,可得到质量相似的产品。两种策略的比较表明,两步式ATPS路线更适合于高细胞密度的培养,而单步式EBA方法更适合中等细胞密度的培养。这是由于以下事实:EBA的应用仅限于湿重细胞浓度为10-12.5%的悬浮液,因此必须在样品应用之前稀释原始肉汤。所提供的数据表明,对于最初在固液分离过程中出现问题的系统,综合回收操作是传统处理的一种有价值的替代方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号